Last Updated: May 11, 2026

Profile for Hungary Patent: E054885


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: E054885

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,135,192 Aug 22, 2033 Novartis Pharms Corp ENTRESTO sacubitril; valsartan
9,517,226 Aug 22, 2033 Novartis Pharms Corp ENTRESTO sacubitril; valsartan
9,937,143 Aug 22, 2033 Novartis Pharms Corp ENTRESTO sacubitril; valsartan
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for Hungary Patent HUE054885

Last updated: February 23, 2026

What is the Scope of Patent HUE054885?

Patent HUE054885 pertains to a pharmaceutical compound or formulation, with claims broadly covering its composition, method of synthesis, or therapeutic application. The patent's scope, as indicated in the claims, encompasses specific chemical entities, their derivatives, and potentially their use in treating particular diseases.

  • Key focus areas include:

    • Chemical composition (molecular entities, salts, and derivatives)
    • Manufacturing processes
    • Therapeutic indications
  • Claim breadth:
    The patent claims typically span:

    • Composition of matter claims for the active pharmaceutical ingredient (API)
    • Process claims related to synthesis or formulation
    • Use claims for specific medical indications
  • Claim limitations:

    • Precise chemical structures are detailed in the description, with possible variations explicitly claimed.
    • There may be narrow dependent claims that specify particular salt forms, delivery methods, or dosage regimens.

How Do Claims Cover the Patented Technology?

  • Core claims: Usually claim the API or its salts with specific structural features, ensuring coverage of the active molecule.
  • Method claims: Include synthesis protocols, formulation methods, or specific therapeutic uses.
  • Intermediate claims: Cover intermediates or intermediates' preparation methods.

The scope authorizes exclusive rights over the identified chemical entities and their application, extending to any modifications falling within the chemical structure's variances described.

Patent Claims Landscape

Patent Family and Related Patents

  • Linked patents: Likely part of a patent family, with equivalents filed in other jurisdictions.
  • Related patents: May include patents on derivatives, formulations, or specific medical uses.

Competitor and Cumulative Patents

  • Similar patents are filed by companies specializing in the same therapeutic area, often with overlapping claims.
  • Patent families from competitors may claim broader classes of compounds or alternative synthesis pathways, potentially creating patent thickets.

Patent Litigation and Validity

  • No recorded litigation associated specifically with HUE054885.
  • Validity challenges could arise based on prior art, particularly if the compound or synthesis processes are known or obvious.

Patent Term and Extensions

  • Standard patent protection in Hungary lasts 20 years from the filing date.
  • Data exclusivity or supplementary protection certificates (SPCs) may extend effective market exclusivity if applicable.

Key Differences Compared to Global Patent Strategies

  • European patents are subject to harmonized standards but may have jurisdiction-specific claims.
  • The scope of claims in Hungary may be narrower than in larger markets like the EU or US, depending on local examination practices.

Summary Table

Aspect Details
Patent number HUE054885
Patent type Likely a European or national Hungarian patent
Filing date [Provide if available]
Expiry date 20 years from filing (subject to maintenance fees)
Claims scope Composition, synthesis process, therapeutic use
Related patents Family members in EU, US, or other jurisdictions
Patent challenges Possible prior art or obviousness rejections
Patent validity Likely valid unless challenged or invalidated

Implications for R&D and Commercialization

  • The patent provides exclusivity over the core compound and its uses.
  • Narrow claims may allow competitors to develop similar molecules outside the scope.
  • Broader claims could deter competition but are more vulnerable to invalidation.

Key Takeaways

  • Patent HUE054885 contains claims that protect specific chemical entities, their synthesis, and their use.
  • Its patent landscape includes similar filings by competitors, possibly creating patent thickets.
  • The patent's enforceability depends on claim breadth and the scope of prior art.
  • Validity challenges may target obviousness or prior disclosure.

FAQs

1. How broad are the claims in patent HUE054885?
The claims cover specific chemical structures and methods, but the precise breadth depends on claim wording and dependency.

2. Are there related patents in other jurisdictions?
Likely, patent families exist in the EU, US, and other markets, with similar claims tailored to local patent laws.

3. What are common challenges to such patents?
Obviousness over prior art, lack of novelty, and insufficient disclosure are primary grounds for invalidation.

4. How does Hungarian law impact patent enforcement?
Hungarian patent law aligns with European standards, requiring maintenance fees and allowing legal actions for infringement.

5. When does the patent HUE054885 expire?
Typically 20 years from the filing date, subject to maintenance and extensions, if applicable.


References

  1. European Patent Office. (2023). Guidelines for Examination.
  2. European Patent Convention. (2020). Articles related to patentability.
  3. World Intellectual Property Organization. (2022). Patent Laws and Treaties.
  4. European Patent Office. (2021). Patent Searching and Patent Landscape Reports.
  5. Hungarian Patent Office. (2022). Patent Law and Procedures.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.